News

Swissmedic Approves IFINWIL® (Eflornithine) For Children Diagnosed With High-Risk Neuroblastoma (HRNB)
IFINWIL®: now approved in Switzerland1 <li /> Nine out of 10 cases of neuroblastoma occur in children under the age ...
Norgine: Swissmedic approves IFINWIL (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)
IFINWIL®: now approved in Switzerland1Nine out of 10 cases of neuroblastoma occur in children under the age of five2The average survival rate of children with HRNB is only 50%2UXBRIDGE, England ...